• 1. Estimation of hydrogen sulfide from crude petroleum: a unique invention using a simple chemosensor?
  Shampa Kundu,Prithidipa Sahoo New J. Chem., 2019,43, 12369-12374
• 2. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 3. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 4. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 5. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837

Comprehensive Analysis of 8-Fluoro-4-methylquinoline (CAS No. 31698-56-3): Properties, Applications, and Industry Trends

8-Fluoro-4-methylquinoline (CAS No. 31698-56-3) is a fluorinated quinoline derivative that has garnered significant attention in pharmaceutical and agrochemical research. This heterocyclic compound features a quinoline backbone substituted with a fluoro group at the 8-position and a methyl group at the 4-position, which collectively enhance its biological activity and metabolic stability. Recent studies highlight its potential as a key intermediate in the synthesis of novel antimicrobial agents and fluorescence probes, aligning with the growing demand for targeted drug discovery and diagnostic tools.

The structural uniqueness of 8-fluoro-4-methylquinoline contributes to its enhanced lipophilicity and electron-withdrawing properties, making it valuable for medicinal chemistry optimization. Researchers are particularly interested in its role in developing kinase inhibitors, a hot topic in oncology research, where fluorinated compounds show improved binding affinity to ATP pockets. Industry reports indicate a 25% annual growth in demand for such fluorinated building blocks, driven by advancements in personalized medicine and high-throughput screening technologies.

From a synthetic perspective, 31698-56-3 is typically produced via Skraup synthesis or Friedl?nder condensation, with recent innovations focusing on catalytic fluorination to improve yield. Analytical characterization using LC-MS and NMR spectroscopy confirms its high purity (>98%), a critical parameter for GMP-compliant applications. The compound's UV absorption at 254 nm also makes it suitable for HPLC method development, addressing frequent user queries about chromatographic separation of fluorinated analogs.

Environmental and regulatory aspects of 8-fluoro-4-methylquinoline follow REACH compliance standards, with biodegradability studies showing moderate persistence. Its low ecotoxicity profile positions it favorably compared to brominated counterparts, responding to industry concerns about sustainable chemistry. Patent analysis reveals increasing applications in OLED materials, where its electron transport properties contribute to energy-efficient displays—a trending topic in green technology forums.

Market intelligence suggests that 31698-56-3 is primarily supplied by specialty chemical manufacturers in Europe and Asia, with pricing influenced by fluoroquinoline market trends. Quality certifications like ISO 9001 and halal compliance documentation are increasingly requested, reflecting diverse industrial requirements. For researchers troubleshooting solubility issues, dimethyl sulfoxide (DMSO) is recommended as the optimal solvent, a practical solution frequently searched in laboratory forums.

Future prospects for 8-fluoro-4-methylquinoline include exploration in bioorthogonal chemistry and proteolysis-targeting chimeras (PROTACs), cutting-edge areas receiving substantial NIH funding. Its compatibility with click chemistry reactions opens possibilities for bioconjugation, addressing another common search term among chemical biologists. As the pharmaceutical industry shifts toward fragment-based drug design, this compound's molecular weight (175.18 g/mol) and logP value (2.1) make it an ideal candidate for lead compound development.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)